Comparison of Tocilizumab and Anakinra in the Treatment of COVID-19: A Single-Center Experience

Comparison of Tocilizumab and Anakinra in the Treatment of COVID-19: A Single-Center Experience

Aim: The aim of this study was to examine whether a difference between endotracheal intubation, non-invasive mechanical ventilation, high flow oxygen therapy requirements and 28-day mortality rate in severe and critical coronavirus disease 2019 (COVID-19) patients receiving anakinra and tocilizumab...

Full description

Bibliographic Details
Main Authors: Bengisu Pınar Acat, Ahmet Tezce, Özben Çavdar, Murat Acat
Format: Article
Language:English
Published: Duzce University 2022-08-01
Series:Düzce Tıp Fakültesi Dergisi
Subjects:
anakinra
covid-19
tocilizumab
Online Access:https://dergipark.org.tr/en/download/article-file/2294707

Similar Items

Similar Items